Press release -
Novus Scientific Leads Evolution of Long-Term Absorbable Meshes on the Soft Tissue Repair Market with TIGR® Matrix Surgical Mesh
Novus Scientific today announced that the successful adoption of long-term absorbable surgical meshes in the market for soft tissue repair devices has been acknowledged in a new report issued by Millennium Research Group, Inc. The report, “U.S. Markets for Soft Tissue Repair 2012” highlights that synthetic absorbable meshes are beginning to compete for sales within the market by offering the benefits of both biologic products and non-absorbable synthetic meshes.
TIGR® Matrix by Novus Scientific is the archetypal long-term absorbable mesh and is used in soft tissue reinforcement applications by both plastic and general surgeons in a growing list of countries, worldwide.
“We have set out to reshape the landscape of soft tissue surgery and to provide plastic and general surgeons with a new, unique tool that will help them produce better patient outcomes.” said Thomas Engström, founder and CEO of Novus Scientific. “It is encouraging to see how well customers, patients and now also analysts have reacted to us introducing new technology to a standstill market. But we are far from finished yet, improving patient care is our ongoing mission.”
TIGR® Matrix Surgical Mesh is the World’s 1st Long-Term Resorbable, (100% Absorbable) Synthetic Mesh indicated for reinforcement of soft tissue where weakness exists. Its unique patented dual-fiber construction is designed for gradually increasing mechanical compliance, making it strong for 6 months and gone in 3 years. The US Food and Drug Administration (FDA) gave the company 510(k) clearance to market TIGR® Matrix Surgical Mesh in February 2010. In August 2011 Novus Scientific received CE Mark approval from BSI for TIGR® Matrix Surgical Mesh in Europe.
TIGR® Matrix Surgical Mesh is available for sale in the U.S. and selected countries in Europe and Asia.
The report “US Markets for Soft Tissue Repair 2012” is available from Millennium Research Group Inc.
Related links
Topics
- Health, Health Care, Pharmaceuticals
Categories
- synthetic
- surgical mesh
- resorbable
- novus scientific
- mesh
- matrix
- engström
- absorbable
- tigr matrix
About Novus Scientific
Novus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of resorbable (100% absorbable) synthetic medical devices. Global HQ is in Singapore while European Headquarters and the core R&D function are in Uppsala, Sweden. The company’s roots are Swedish as all the founders of Novus Scientific are previous owners / senior managers / members of the soft tissue-engineering project within Uppsala-based, Radi Medical Systems AB (now owned by St. Jude Medical Inc). The US Division, Novus Scientific, Inc. is headquartered near Boston, one of the world’s foremost medical research cities. From this hub, Novus Scientific, Inc. will distribute TIGR® Matrix Surgical Mesh throughout the United States.
TIGR® Matrix - The world’s 1st long-term resorbable, 100% absorbable synthetic mesh with unique patented dual-fiber construction, designed for gradually increasing mechanical compliance.
TIGR® is a registered trademark of Novus Scientific Pte. Ltd
